Published in J Sex Med on September 12, 2012
Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial. BJU Int (2015) 1.39
Exercise prevents Western diet-associated erectile dysfunction and coronary artery endothelial dysfunction: response to acute apocynin and sepiapterin treatment. Am J Physiol Regul Integr Comp Physiol (2013) 0.84
Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction. J Sex Med (2013) 0.84
Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic heart disease. Int J Impot Res (2015) 0.82
Immunization associated with erectile dysfunction based on cross-sectional and genetic analyses. PLoS One (2014) 0.76
Depressive symptoms in patients diagnosed with benign prostatic hyperplasia. Int Urol Nephrol (2015) 0.76
Sexual dysfunction in 2013: Advances in epidemiology, diagnosis and treatment. Arab J Urol (2013) 0.75
Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats. PLoS One (2015) 0.75
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (2006) 3.23
RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A (2004) 2.53
An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med (2008) 1.95
An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med (2014) 1.91
International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med (2010) 1.60
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun (2002) 1.53
Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease. J Sex Med (2013) 1.52
Gene therapy for erectile dysfunction: fact or fiction? Eur Urol (2006) 1.51
The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol (2007) 1.49
Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study. Eur Urol (2006) 1.45
Peripheral mechanisms of erectile dysfunction in a rat model of chronic cocaine use. Eur Urol (2007) 1.44
Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement. J Sex Med (2013) 1.43
Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol (2006) 1.41
Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl (2003) 1.37
Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase. Am J Physiol Heart Circ Physiol (2006) 1.34
Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl (2003) 1.32
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol (2003) 1.22
Best practice policies for male infertility. J Urol (2002) 1.21
Standard operating procedures for priapism. J Sex Med (2012) 1.16
Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med (2011) 1.14
Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med (2005) 1.10
Re: long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery. J Urol (2012) 1.08
Current concepts in the management of erectile dysfunction in men with prostate cancer. Clin Prostate Cancer (2004) 1.06
Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options. Expert Opin Pharmacother (2011) 1.05
Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci U S A (2012) 1.04
Infection retardant coated inflatable penile prostheses decrease the incidence of infection: a systematic review and meta-analysis. J Urol (2012) 1.02
Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction. Curr Opin Investig Drugs (2006) 0.99
The hydrophilic-coated inflatable penile prosthesis: 1-year experience. J Sex Med (2004) 0.98
Managing the difficult penile prosthesis patient. J Sex Med (2013) 0.97
Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother (2010) 0.97
The pharmacological treatment of premature ejaculation. BJU Int (2008) 0.97
Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. J Sex Med (2012) 0.96
Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction. Expert Opin Investig Drugs (2010) 0.96
The penile implant for erectile dysfunction. J Sex Med (2004) 0.96
5-alpha reductase inhibitors and erectile dysfunction: the connection. J Sex Med (2008) 0.96
Patient and partner satisfaction and long-term results after surgical treatment for Peyronie's disease. Urology (2003) 0.93
Gene transfer of extracellular SOD to the penis reduces O2-* and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol (2002) 0.93
Critical analysis of surgery for Peyronie's disease. Curr Opin Urol (2004) 0.93
Purinergic (P2) receptor control of lower genitourinary tract function and new avenues for drug action: an overview. Curr Pharm Des (2007) 0.93
Treatment of Peyronie's disease: 2012 update. Curr Urol Rep (2011) 0.92
The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. J Sex Med (2006) 0.92
Long-term revision rate due to infection in hydrophilic-coated inflatable penile prostheses: 11-year follow-up. J Sex Med (2012) 0.92
Update on erectile dysfunction in prostate cancer patients. Curr Opin Urol (2006) 0.91
Long-term outcomes of penile prostheses for the treatment of erectile dysfunction. Expert Rev Med Devices (2013) 0.91
Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury. J Urol (2005) 0.91
Sexual function and depressive symptoms among female North American medical students. J Sex Med (2010) 0.90
The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol (2003) 0.90
Stratification of penile vascular pathologies in patients with Peyronie's disease and in men with erectile dysfunction according to age: a comparative study. J Urol (2004) 0.90
Synchronous prosthetic implantation through a transscrotal incision: an outcome analysis. J Urol (2006) 0.90
The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease. J Sex Med (2005) 0.89
Pharmacological Management of Peyronie's Disease. Drugs (2007) 0.87
Current concepts in ejaculatory dysfunction. Rev Urol (2006) 0.87
Current updates on laboratory techniques for the diagnosis of male reproductive failure. Asian J Androl (2016) 0.86
Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease. J Urol (2013) 0.86
The impact of vascular risk factors on erectile function. Drugs Today (Barc) (2005) 0.86
Diabetes mellitus is associated with severe Peyronie's disease. BJU Int (2007) 0.86
Gene therapy techniques for the delivery of endothelial nitric oxide synthase to the corpora cavernosa for erectile dysfunction. Methods Mol Biol (2004) 0.85
Premature ejaculation: current and future treatments. Asian J Androl (2008) 0.85
The relationship between the type of penile abnormality and penile vascular status in patients with peyronie's disease. J Urol (2005) 0.85
Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors. J Sex Med (2014) 0.85
Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation. Curr Opin Investig Drugs (2009) 0.84
Amelioration of gentamicin nephrotoxicity by green tea extract in uninephrectomized rats as a model of progressive renal failure. Ren Fail (2010) 0.84
Sex and the infertile male. Semin Reprod Med (2009) 0.84
A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. J Sex Med (2012) 0.84
Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology (2004) 0.83
Male circumcision and HIV prevention. J Sex Med (2007) 0.83
Sexual dysfunction following radical prostatectomy. J Androl (2012) 0.83
Emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs (2015) 0.82
Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue. Urology (2011) 0.82
Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil. BJU Int (2009) 0.82
A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats. J Sex Med (2010) 0.82
Strategies for penile prosthesis placement in Peyronie's disease and corporal fibrosis. Curr Urol Rep (2015) 0.81
A comparison of the NADPH oxidase in human sperm and white blood cells. Int J Androl (2002) 0.81
Is testosterone a friend or a foe of the prostate? J Sex Med (2011) 0.81
Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction. BJU Int (2008) 0.81
The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment. BJU Int (2004) 0.80
A critical appraisal of erectile function in animal models of diabetes mellitus. Int J Androl (2008) 0.80
The growing concerns regarding counterfeit medications. J Sex Med (2011) 0.80
The impact of infertility on family size in the USA: data from the National Survey of Family Growth. Hum Reprod (2010) 0.80
Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new RTK targets. Urology (2013) 0.80
Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction. Drugs (2008) 0.80
Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats. J Androl (2009) 0.79
Localization of peripheral dopamine D1 and D2 receptors in rat and human seminal vesicles. J Androl (2002) 0.79
Analysis of erectile responses to imatinib in the rat. Urology (2013) 0.79
Endothelial nitric oxide synthase gene therapy for erectile dysfunction. Curr Pharm Des (2005) 0.79
Type 5 phosphodiesterase inhibitors: curing erectile dysfunction. Eur Urol (2006) 0.79
Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha. BJU Int (2007) 0.79
Words of Wisdom. Re: treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. Eur Urol (2011) 0.79
Incision and grafting for severe Peyronie's disease (CME). J Sex Med (2009) 0.79
Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease. J Urol (2004) 0.79
Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction. Curr Pharm Des (2010) 0.79